Industry Involvement
In establishing its systems and processes, SMC has worked collaboratively in building positive relationships with the Association of British Pharmaceutical Industry (ABPI). Representatives of ABPI have been involved with the SMC and its processes from an early stage. SMC and ABPI have fostered a strong relationship and ABPI continues to offer unfailing commitment to the process with representation on both the New Drugs Committee (NDC) and SMC.
The SMC User Group Forum first met in August 2002 and comprises representatives of the pharmaceutical industry - people with hands on experience of handling Health Technology issues for companies – who meet quarterly, with those from the SMC, including representatives of the SMC Executive, the NDC, pharmacy and health economic assessors and the secretariat. The aim of the group is to identify, address and resolve process issues relating to the work of the SMC.